ULTOMIRIS — ALEXION PHARM, approved 2026-06-01 (BLA761108).
8,439 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.